EpistemisSummary of interactions and risks of antidotes
The administration of antidotes in critically ill patients requires knowing their systemic metabolic risk profile and possible cross-interactions with common drugs for hospital use:
File
| Involved Antidote | Therapeutic Target | High Risk Interaction | Physiopathological Mechanism | Preventive Clinical Recommendation |
|---|---|---|---|---|
| Flumazenil | Benzodiazepines | Tricyclic antidepressants (e.g. Amitriptyline) | The reversal of GABA sedation leaves the brain unprotected against sodium channel blockade that induces severe epileptic seizures and ventricular arrhythmias. | Absolutely avoid its use if there is suspicion of concomitant intake of tricyclics or widening of the QRS complex on the surface electrocardiogram. |
| Methylene Blue | Methemoglobin | Selective Serotonin Reuptake Inhibitors (SSRIs) | Methylene blue has potent intrinsic inhibitory properties of monoamine oxidase type A (MAOI-A), inducing an excess of synaptic serotonin. | Risk of precipitation of a Severe Serotonin Syndrome hyperthermia and autonomic collapse. Rigorously monitor neurological status. |
| Naloxone | Opioid Receptors | Ischemic heart disease or previous arrhythmias | Sudden withdrawal of the opiate depressant tone causes a massive discharge of endogenous adrenal catecholamines (rebound adrenergic storm). | Risk of Hypertensive Crisis and Acute Cardiogenic Lung Edema. Titrate with slow intravenous microdoses of 0.04 mg to avoid abrupt response. |
| Physostigmine | Anticholinergic syndrome | Neuromuscular Blocking Drugs (e.g. Succinylcholine) | Inhibition of acetylcholinesterase blocks the plasma clearance of succinylcholine, prolonging its blocking effect at the neuromuscular junction. | Risk of Prolonged Mechanical Apnea of the patient. Cautiously reduce the dose or delay the administration of depolarizing blockers. |
| Fomepizole | Methanol / Ethylene Glycol | Concomitant Ethanol | Fomepizole blocks the metabolism of ethanol completely, prolonging its elimination half-life indefinitely with an increase in central toxicity. | Immediately discontinue any ethanol infusion that had been started empirically before beginning systemic fomepizole infusion. |
Epistemis is educational review material. It is not a medical device, does not diagnose or prescribe treatment, and does not replace formal medical training, current clinical guidelines, or professional clinical judgment.
- System
- Antidotes and Toxicology
- Cluster
- Toxicological Safety Matrix